热搜词：
注册
登录
CN
  • CN
  • EN

产品中心 药物靶点和Fc受体 药物靶点

所有图片（1/4）

CD19 His Tag Protein, Human

CD19,B4,CVID3,MGC12802

价格 ￥1,680.00 （ 供应商现货 ： 3-5个工作日）
货号 UA011126
规格
数量
收藏 分享
产品介绍

产品介绍 评论(0)

产品规格

  • 物种

    Human

  • 分子别名

    CD19, B4, CVID3, MGC12802

  • Accession

    P15391-1

  • 表达序列

    Pro 20-Lys 291 with His Tag at C-Terminus

  • 表达宿主

    CHO

  • 分子量

    40-45kDa (Reducing)

  • 纯度

    ＞95% by SDS-PAGE

  • 内毒素含量

    <0.1EU/μg

  • 活性

    Immobilized Denintuzumab (Cat. No. UA011019) at 2.0μg/mL (100μL/well) can bind CD19 His Tag Protein, Human with EC50 of 11.56-19.69ng/mL

  • 标记

    Unconjugated

  • 标签

    His Tag

  • 性状

    Lyophilized Powder

  • 缓冲体系

    PBS, PH7.4, 5% trehalose

  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.

  • 文献引用

    Wang SY, An WH, Wang ZS, Wang WL, Zhang B, Xu KL, Guo SL, Gao M, Li B, Huang L, Tian HH, Guo WY, Wang HR. Incidentally cured psoriasis in a patient with refractory/relapsed diffuse large B-cell lymphoma receiving CD19 CAR-T cell therapy: a case report. Front Immunol. 2024 Oct 24; 15: 1418768.

背景介绍

  • CD19, also known as B-lymphocyte antigen or Cluster of Differentiation 19, is a single-pass type I membrane protein that contains two Ig-like C2-type (immunoglobulin-like) domains. It is expressed on follicular dendritic cells and B cells, being present from the earliest recognizable B-lineage cells during development to B-cell blasts, but is lost upon maturation to plasma cells. CD19 primarily functions as a B cell co-receptor in conjunction with CD21 and CD81. Upon activation, the cytoplasmic tail of CD19 becomes phosphorylated, leading to binding by Src-family kinases and recruitment of PI-3 kinase. Mutations in the CD19 gene are associated with severe immunodeficiency syndromes, characterized by diminished antibody production. CD19 has been shown to interact with CD81, CD82, Complement receptor 2, and VAV2.

  • 电泳

    • 2μg (R: reducing condition, N: non-reducing condition).

  • ELISA

    • Immobilized Denintuzumab (Cat. No. UA011019) at 2.0μg/mL (100μL/well) can bind CD19 His Tag Protein, Human with EC50 of 11.56-19.69ng/mL.

    • Immobilized FMC63 at 2.0μg/mL (100μL/well) can bind CD19 His Tag Protein, Human with EC50 of 2.71-4.27ng/mL.

    • Immobilized FMC63（Cat. UA016023） at 2.0μg/mL (100μL/well) can bind CD19 His Tag Protein, Human (Cat. No. UA011126) with EC50 of 9.03-12.82 ng/mL.

评论(0)